Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 16/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.42 |
| ▸ | FNTB | P49356 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21644754 | 1.00 | GPR119 (0.51) | GPR119HPGDRECQLFNTAFNTB | |
| SCHEMBL21405347 | 0.94 | GPR119 (0.53) | GPR119 | |
| SCHEMBL21456063 | 0.94 | GPR119 (0.53) | GPR119 | |
| SCHEMBL23205355 | 0.94 | GPR119 (0.53) | GPR119 | |
| SCHEMBL21673925 | 0.89 | GPR119 (0.47) | GPR119 | |
| SCHEMBL21644749 | 0.89 | GPR119 (0.47) | GPR119 | |
| SCHEMBL22156950 | 0.86 | GPR119 (0.53) | GPR119 | |
| SCHEMBL25278138 | 0.85 | GPR119 (0.45) | GPR119 | |
| SCHEMBL25626363 | 0.85 | GPR119 (0.45) | GPR119 | |
| SCHEMBL20120962 | 0.82 | GPR119 (0.64) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023097031-A1 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| WO-2021067606-A1 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. (US) | 2021-04-08 | — | — | WO | disclosed |